Celon Pharma S.A. (CLN.WA)
PLN 25.35
(0.2%)
PLN 25.35
(0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 164.39 Million | 161.91 Million | 169.55 Million | 139.27 Million | 102.24 Million | 125.24 Million |
| Cost of Revenue | 66.81 Million | 66.46 Million | 61.71 Million | 32.01 Million | 23.35 Million | 28.17 Million |
| Gross Profit | 97.57 Million | 95.45 Million | 107.84 Million | 107.25 Million | 78.89 Million | 97.06 Million |
| Operating Expenses | 174.34 Million | 132.74 Million | 118.42 Million | 69.94 Million | 72.67 Million | 61.73 Million |
| Selling, General and Administrative Expenses | 111.12 Million | 13.1 Million | 37.38 Million | 10.94 Million | 15.87 Million | 18.33 Million |
| Research and Development Expenses | 680 Thousand | 62.99 Million | 49.05 Million | 42.25 Million | - | - |
| Other Expenses | 62.54 Million | 132.74 Million | 81.04 Million | 58.99 Million | 56.79 Million | 43.39 Million |
| Cost and Expenses | 191.63 Million | 199.21 Million | 180.14 Million | 101.95 Million | 96.02 Million | 89.91 Million |
| Operating Income | -27.24 Million | -34.73 Million | -13.66 Million | 36.81 Million | 6.89 Million | 35.61 Million |
| Interest Expense | 2.66 Million | 1.67 Million | 1.55 Million | 561 Thousand | 185.65 Thousand | 1.14 Million |
| Income Tax Expense | 8.15 Million | 2.83 Million | -3.48 Million | 574 Thousand | -4.12 Million | 7.79 Million |
| Earnings before Tax | -19.96 Million | -36.44 Million | -15.08 Million | 22.06 Million | 7.8 Million | 37.49 Million |
| Net Income | -28.12 Million | -39.27 Million | -11.6 Million | 21.49 Million | 11.93 Million | 29.69 Million |
| Earnings Per Share Basic | -0.55 | -0.77 | -0.25 | 0.48 | 0.27 | 0.66 |
| Earnings Per Share Diluted | -0.55 | -0.77 | -0.25 | 0.48 | 0.27 | 0.66 |
| Weighted Average Shares Outstanding | 51.05 Million | 51.02 Million | 46.67 Million | 45 Million | 45 Million | 45 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.05 Million | 51.02 Million | 46.67 Million | 45 Million | 45 Million | 45 Million |
| Gross Margin | 0.59 | 0.59 | 0.64 | 0.77 | 0.77 | 0.78 |
| EBIT Margin | 0.20 | 0.06 | 0.16 | 0.49 | 0.27 | 0.44 |
| Profit Margin | -0.17 | -0.24 | -0.07 | 0.15 | 0.12 | 0.24 |
| EBITDA | 32.71 Million | 9.32 Million | 27.8 Million | 30.37 Million | 26.83 Million | 55.85 Million |
| Earnings Before Tax Margin | -0.17 | -0.21 | -0.08 | 0.26 | 0.07 | 0.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 53.58 Million | 36.31 Million | 164.39 Million | 40.66 Million | 42.5 Million | 42.22 Million |
| Cost of Revenue | 17.22 Million | 53.54 Million | 66.81 Million | 16.01 Million | 16.33 Million | 16.16 Million |
| Gross Profit | 36.35 Million | -17.22 Million | 97.57 Million | 24.64 Million | 26.17 Million | 26.06 Million |
| Operating Expenses | 43.26 Million | 4.6 Million | 128.57 Million | 35.09 Million | 36.68 Million | 14.9 Million |
| Selling, General and Administrative Expenses | 34.05 Million | 4.6 Million | - | 29.92 Million | 2.13 Million | 4.75 Million |
| Research and Development Expenses | - | 680 Thousand | - | 680 Thousand | - | - |
| Other Expenses | -10 Thousand | 143 Thousand | 743 Thousand | 360 Thousand | 376 Thousand | 987 Thousand |
| Cost and Expenses | 60.48 Million | 58.14 Million | 195.39 Million | 51.11 Million | 53.01 Million | 31.07 Million |
| Operating Income | -6.81 Million | -21.82 Million | -27.24 Million | -9.27 Million | -9.76 Million | 11.41 Million |
| Interest Expense | 675 Thousand | 623 Thousand | 2.66 Million | 560 Thousand | 604 Thousand | 685 Thousand |
| Income Tax Expense | -2.32 Million | 2.81 Million | 8.15 Million | 7.55 Million | -1.25 Million | 3.95 Million |
| Earnings before Tax | -10.35 Million | -12.85 Million | -19.96 Million | -7.41 Million | -8.06 Million | 13.09 Million |
| Net Income | -8.02 Million | -15.67 Million | -28.12 Million | -14.96 Million | -6.81 Million | 9.14 Million |
| Earnings Per Share Basic | -0.15 | -0.31 | - | -0.29 | -0.13 | 0.18 |
| Earnings Per Share Diluted | -0.15 | -0.31 | - | -0.29 | -0.13 | 0.18 |
| Weighted Average Shares Outstanding | 53.5 Million | 51.05 Million | 51.05 Million | 51.36 Million | 51.05 Million | 51.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.5 Million | 51.05 Million | 51.05 Million | 51.36 Million | 51.05 Million | 51.05 Million |
| Gross Margin | 0.68 | -0.47 | 0.59 | 0.61 | 0.62 | 0.62 |
| EBIT Margin | 0.16 | -0.25 | - | 0.10 | 0.06 | 0.57 |
| Profit Margin | -0.15 | -0.43 | -0.17 | -0.37 | -0.16 | 0.22 |
| EBITDA | 8.46 Million | -9.09 Million | - | 4.11 Million | 2.45 Million | 23.93 Million |
| Earnings Before Tax Margin | -0.13 | -0.60 | -0.17 | -0.23 | -0.23 | 0.27 |
ENTRINT
JETAIRWAYS
290650
DGE
GUER
AGYTF